Zdrowie i gospodarka · 29/02/2012
FDA Clears Path for Abbreviated Approval of Phenacemide Tablet
The FDA has ruled that the 500mg phenacemide tablet was not withdrawn from sale due to safety or effectiveness concerns, paving the way for potential approval of generic versions of the medication.